亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Gene-Expression Signatures that Identify Cirrhosis Patients "At Risk" for Liver Cancer and Predict the Probability of HCC Recurrence Following Early-Stage Diagnosis and Resection

详细技术说明
None
*Abstract
Knowing an individualΓÇÖs susceptibility to cancer recurrence in advance could lead to significant health gains as well as lower health costs. There is an urgent need to (1) identify "at risk" patients, and (2) sort out those patients with the greatest risk of experiencing cancer recurrence after "standard of care" chemotherapy so that appropriate treatment decisions can be made. Gene-expression profiling of cancer is an effective method to do such "sorting." Scientists in the Golub lab discovered and validated two different gene expression signatures that predict either a poor survival outcome (73 gene signature) or good survival outcome (113 gene signature) in early stage hepatocellular cancer ("HCC") (liver cancer) patients.
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备